Respiratory infections—from influenza/RSV/SARS-CoV-2 and atypicals (Mycoplasma, Chlamydophila) to Bordetella pertussis, Legionella, Streptococcus pneumoniae, Mycobacterium tuberculosis, and key fungal pathogens—demand rapid, accurate diagnostics to triage patients and guide therapy. At Southern Medical Supplies Limited (SMSL), we offer a full workflow spanning syndromic multiplex NAAT/RT-PCR panels and targeted PCR, rapid antigen and high-sensitivity immunoassays, urinary antigens (Legionella, S. pneumoniae), serology where appropriate, culture with rapid ID/AST, and stewardship markers (procalcitonin, CRP). For TB, we support molecular detection plus IGRA screening; for invasive mycoses, options include galactomannan and cryptococcal antigen. End-to-end consumables—NP/OP swabs, VTM/UTM, sputum/BAL collection—and clear reflex algorithms round out the service. Our portfolio spans ELISA, chemiluminescent immunoassay, molecular, microbiology, and clinical chemistry platforms sourced from a broad network of trusted partners: EUROIMMUN, Ansh Labs, Randox, Streck, Bio-Rad, Abbott, Roche, Siemens Healthineers, Qiagen, bioMérieux, Cepheid, Werfen, Globe Scientific, ELGA LabWater, LW Scientific, Sebia, LTA SRL, Acrobiotech, MAKOL Innovacion Medica, Rayto Life and Analytical Sciences, Diazyme, Hardy’s Diagnostics, and Teco Diagnostics—delivering the speed, sensitivity, and reproducibility clinicians need for confident respiratory infection management.